JP2024540241A5 - - Google Patents
Info
- Publication number
- JP2024540241A5 JP2024540241A5 JP2024525932A JP2024525932A JP2024540241A5 JP 2024540241 A5 JP2024540241 A5 JP 2024540241A5 JP 2024525932 A JP2024525932 A JP 2024525932A JP 2024525932 A JP2024525932 A JP 2024525932A JP 2024540241 A5 JP2024540241 A5 JP 2024540241A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- compound
- prodrug
- solvate
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163272743P | 2021-10-28 | 2021-10-28 | |
| US63/272,743 | 2021-10-28 | ||
| PCT/US2022/078779 WO2023076997A1 (en) | 2021-10-28 | 2022-10-27 | Modified forms of ambroxol for therapeutic use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540241A JP2024540241A (ja) | 2024-10-31 |
| JP2024540241A5 true JP2024540241A5 (enExample) | 2025-11-04 |
Family
ID=84364209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525932A Pending JP2024540241A (ja) | 2021-10-28 | 2022-10-27 | 治療上の使用のためのアンブロキソールの修飾形態 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250235413A1 (enExample) |
| EP (1) | EP4423041A1 (enExample) |
| JP (1) | JP2024540241A (enExample) |
| KR (1) | KR20240095271A (enExample) |
| CN (1) | CN118660866A (enExample) |
| CA (1) | CA3235692A1 (enExample) |
| WO (1) | WO2023076997A1 (enExample) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| US5354566A (en) | 1993-06-02 | 1994-10-11 | Kraft General Foods, Inc. | Preparation of yeast-leavened dough crusts |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| US6440710B1 (en) * | 1998-12-10 | 2002-08-27 | The Scripps Research Institute | Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds |
| DK1104760T3 (da) * | 1999-12-03 | 2003-06-30 | Pfizer Prod Inc | Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler |
| IL160539A0 (en) | 2001-09-04 | 2004-07-25 | Boehringer Ingelheim Int | Anti-influenzal agents |
| TW200413273A (en) * | 2002-11-15 | 2004-08-01 | Wako Pure Chem Ind Ltd | Heavy hydrogenation method of heterocyclic rings |
| DE10332487A1 (de) | 2003-07-16 | 2005-02-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen |
| US7750168B2 (en) * | 2006-02-10 | 2010-07-06 | Sigma-Aldrich Co. | Stabilized deuteroborane-tetrahydrofuran complex |
| CA3055311A1 (en) * | 2017-02-07 | 2018-08-16 | Stc.Unm | Isotope enhanced ambroxol for long lasting autophagy induction |
| CN114907221A (zh) * | 2021-02-06 | 2022-08-16 | 华创合成制药股份有限公司 | 一种氘代氨溴索衍生物及其制备和用途 |
-
2022
- 2022-10-27 CN CN202280079899.3A patent/CN118660866A/zh active Pending
- 2022-10-27 EP EP22813844.2A patent/EP4423041A1/en active Pending
- 2022-10-27 WO PCT/US2022/078779 patent/WO2023076997A1/en not_active Ceased
- 2022-10-27 JP JP2024525932A patent/JP2024540241A/ja active Pending
- 2022-10-27 US US18/705,344 patent/US20250235413A1/en active Pending
- 2022-10-27 KR KR1020247017158A patent/KR20240095271A/ko active Pending
- 2022-10-27 CA CA3235692A patent/CA3235692A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7185426B2 (ja) | Ｓ１ｐ受容体モジュレーターの投与計画 | |
| CN102216281B (zh) | 依帕司他的新胆碱共结晶 | |
| CN106999462B (zh) | 包含选择性s1p1受体激动剂的药物组合物 | |
| JP2006522740A5 (enExample) | ||
| CN113473981A (zh) | 含肉桂酸的组合物以及其使用方法 | |
| CN107709291A (zh) | 抑制剂及其应用 | |
| CN120225188A (zh) | Slc6a19功能哌啶抑制剂的晶体形式 | |
| WO2024153813A1 (en) | Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting | |
| JP2022507812A5 (enExample) | ||
| JP5328244B2 (ja) | 筋萎縮性側索硬化症治療剤 | |
| MX2007008845A (es) | Metodos para control del intervalo qt. | |
| WO1996011685A2 (en) | Use of indole derivatives for the treatment of various diseases | |
| BR112015002979B1 (pt) | forma cristalina, e, composição farmacêutica | |
| JP2003201255A (ja) | アルツハイマー病予防および治療剤 | |
| JPH05148143A (ja) | 抗糖尿病薬 | |
| 陳才雄 et al. | A rare neurological complication due to lithium poisoning | |
| JP2009502945A (ja) | 覚醒を改善する方法 | |
| JP2022536331A (ja) | シヌクレイノパチーの治療 | |
| WO2024170727A1 (en) | Combinations of beta 2-adrenergic receptor agonists and metformin for use in treating obesity and reducing body fat | |
| US20240277662A1 (en) | Administration of a Compound to Individuals with Hepatic Impairment | |
| US12042493B2 (en) | Pharmaceutical compounds for use in treating Huntington's disease | |
| WO2021066136A1 (ja) | 筋ジストロフィー治療薬 | |
| CN115335048A (zh) | 噻吩并吡啶酮衍生物在治疗肾上腺脑白质营养不良或肾上腺脊髓神经病中的用途 | |
| JP2006500357A (ja) | 多発性硬化症を処置するためのトレオスルファンおよびその誘導体の使用 | |
| WO1999011266A1 (en) | Multiple sclerosis remedies |